| Range: | 0.3339-5.39 | Vol Avg: | 504100 | Last Div: | 0 | Changes: | -0.26 |
| Beta: | 0.57 | Cap: | 0.01B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Thu Feb 11 2016 | Empoloyees: | 11 | ||
| CUSIP: | 49461C102 | CIK: | 0001445283 | ISIN: | US49461C1027 | Country: | US |
| CEO: | Mr. Craig W. Philips | Website: | https://kinetabio.com | ||||
KA 0.60 Stock Price Kineta, Inc.
Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow